Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cellsMing Chen, Anna Moore|Frontiers in Molecular Biosciences|2023Cited by 14